Skip to Main Content

Publications Co-authored or Contributed to by Library Staff

Editing Services

Our Editing Services team currently employs 13 editors (including editorial managers), many with more than 25 years of editing experience. The editors perform both substantive editing and copy-editing of grant proposals, journal articles, and other materials. 

Literature Search Services

The Research Services team offers expertise on literature searching, systematic reviews and author and publication metrics to MD Anderson Cancer Center employees. We have years of combined searching experience using a variety of resources including MEDLINE, EMBASE, CINAHL, Web of Science, and many more.

Legend

Symbol Definition
Editing Publications that have been edited.
Searching Publications that have had searching assistance.
Co-Authorship Publications with library co-authors.
Star Publications with two or more types of contributions.

Publications Co-authored or Contributed to by Library Staff

In fiscal year 2021-2022, Research Medical Library staff have co-authored or been acknowledged for their contributions to the following publications. Names of library co-authors are in bold; for publications without a library co-author, the specific library contribution (e.g., Literature Searching; Editing) is noted. View a full list of 2020 contributions.

2022 RML Contributed Publications

RML publications by years

March 2023

Contribution Citation Altmetric Badge
Editing

Guan F, Wang X, Yang M, et al. Dosimetric response of GafchromicTM EBT-XD film to therapeutic protons. Precis Radiat Oncol. 2023 Mar 2.

 
Editing

Cohen EN, Jayachandran G, Gao H, et al. Phenotypic Plasticity in Circulating Tumor Cells Is Associated with Poor Response to Therapy in Metastatic Breast Cancer Patients. Cancers (Basel). 2023 Mar 6;15(5):1616.

 
Editing

Rolston K, Gerges B, Nesher L, Shelburne SA, Prince R, Raad I. In vitro activity of eravacycline and comparator agents against bacterial pathogens isolated from patients with cancer. JAC Antimicrob Resist. 2023 Mar 2;5(2):dlad020.

 
Editing

Pourebrahim R, Montoya RH, Alaniz Z, et al. Mdm2/p53 levels in bone marrow mesenchymal stromal cells is essential for maintaining the hematopoietic niche in response to DNA damage. Res Sq. 2023 Mar 2.

 
Editing

Klingen JT, Mustafayev K, Yibirin M, Hwang JP, Torres HA. False-reactive hepatitis B surface antigen test results in cancer patients. Eur J Clin Microbiol Infect Dis. 2023 Mar;42(3):383-38.

 
Editing

Gjyshi O, Grippin A, Andring L, et al. Circulating neutrophils and tumor-associated myeloid cells function as a powerful biomarker for response to chemoradiation in locally advanced cervical cancer. Clin Transl Radiat Oncol. 2023 March;39:100578.

 

February 2023

Contribution Citation Altmetric Badge
Searching

Xie X, Lee J, Fuson JA, et al. Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines. Biomedicines. 2023 Feb 28;11(3):735.

 
Searching

Zhukovsky DS, Soliman P, Liu D, et al. Patient Engagement With Early Stage Advance Care Planning at a Comprehensive Cancer Center. Oncologist. 2023 Feb 27.

 
Searching

Engler A, Butler B, Tewari P. “The Future Redefined” Pediatric, Adolescent and Young Adult College and Career Fair: A Collaborative Symposium to Provide Proactive Education for Oncology Patients and Survivors. J Adolesc Young Adult Oncol. 2023 Feb 24.

 
Editing

Choi E, Becker H, Lu Q, Roth M. Sex differences in comorbid conditions, health behaviors, health care utilization, and health-related quality of life among young adult cancer survivors. Support Care Cancer. 2023 Feb 23;31(3):181.

 
Editing

Yu G, Zhang W, Zhang H, et al. The multi-kinase inhibitor CG-806 exerts anti-cancer activity against acute myeloid leukemia by co-targeting FLT3, BTK, and Aurora kinases. Res Sq. 2023 Feb 22.

 
Editing

Blumenthaler AN, Robinson KA, Hodge C, et al. Communication Frameworks for Palliative Surgical Consultations: A Randomized Study of Advanced Cancer Patients. Ann Surg. 2023 Feb 21.

 
Co-Author

Ruiz JI, Lopez-Olivo MA, Geng Y, Suarez-Almazor ME. COVID-19 Outcomes in Patients with Cancer Receiving Immune Checkpoint Inhibitors: A Systematic Review. J Immunother Precis Oncol. 2023 Feb 22.

 
Editing

Flores Legarreta A, Salvo G, Gonzales NR, Chisholm G, Hillman RT, Frumovitz M. RB1 alteration and poor prognosis in women with high-grade neuroendocrine carcinoma of the uterine cervix: a NeCTuR study. J Gynecol Oncol. 2023 Feb 9.

 
Editing

Nelson BE, Roszik J, Janku F, et al. BRAF v600E–mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study. NPJ Precis Oncol. 2023 Feb 18;7(1):19.

 
Editing

Zhang S, Kim K-B, Huang Y, et al. CRACD, a gatekeeper restricting proliferation, heterogeneity, and immune evasion of small cell lung cancer. bioRxiv. 2023 Feb 15.

 
Editing

Swartz MC, Robertson MC, Christopherson U, et al. Assessing the Suitability of a Virtual ‘Pink Warrior’ for Older Breast Cancer Survivors during COVID-19: A Pilot Study. Life (Basel). 2023 Feb 18;13(2):574.

 
Editing

Ferri-Borgogno S, Zhu Y, Sheng J, et al. Spatial transcriptomics depict ligand-receptor crosstalk heterogeneity at the tumor-stroma interface in long-term ovarian cancer survivors. Cancer Res. 2023 Feb 14.

 
Editing

Dasari SK, Joseph R, Umamaheswaran S, et al. Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer. Int J Mol Sci. 2023 Feb 15;24(4):3915.

 
Editing

Liu S, Xie S, Liu W, et al. Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment. Res Sq. 2023 Feb 14.

 
Editing

Wang M, Ding Q, Gu J, et al. Breast Cancer with a HER2 FISH Group 2 Result: Should HER2 Tests be Repeated?. Clin Breast Cancer. 2023 Feb 12.

 
Editing

Wei D, Chen D, Mou H, et al. Targeting Glutamine Metabolism with a Novel Na+/K+-ATPase Inhibitor RX108 in Hepatocellular Carcinoma. Mol Cancer Ther. 2023 Feb 10.

 
Editing

Patel B, Zhou Y, Babcock RL, et al. STAT3 protects HSCs from intrinsic interferon signaling and loss of long-term blood-forming activity. bioRxiv. 2023 Feb 11.

 
Editing

Rodriguez-Sevilla JJ, Adema V, Garcia-Manero G, Colla S. Emerging treatments for myelodysplastic syndromes: Biological rationales and clinical translation. Cell Rep Med. 2023 Feb 7.

 
Editing

Gordon MJ, Duan Z, Zhao H, et al. A novel comorbidity score for older adults with non-Hodgkin lymphoma: the 3-factor risk estimate scale. Blood Adv. 2023 Feb 8.

 
Editing

Barcena AJR, Perez JVD, Damasco JA, et al. Gold Nanoparticles for Monitoring of Mesenchymal Stem Cell–Loaded Bioresorbable Polymeric Wraps for Arteriovenous Fistulas. bioRxiv. 2023 Feb 3.

 
Editing

Frenkel M, David A, Sapire K, Hausner D. Complementary and Integrative Medicine in Pancreatic Cancer. Curr Oncol Rep. 2023 Feb 3.

 
Co-Author

Ruiz JI, Lopez-Olivo MA, Geng Y, Suarez-Almazor ME. COVID-19 vaccination in patients with cancer receiving immune checkpoint inhibitors: a systematic review and meta-analysis. J Immunother Cancer. 2023 Feb;11(2):e006246.

 
Editing

Cho WC, Vanderbeck K, Nagarajan P, et al. SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma: Comparative Analysis of SOX11, CK20, PAX5, and TTF1 Expression in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma. Arch Pathol Lab Med. 2023 Feb 6.

 
Editing

Zou J, Kongtim P, Oran B, et al. Molecular disparity of HLA-DPB1 is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantation. Cancer. 2023 Feb 4.

 
Editing

Smith JM, Kapur SK, Mericli AF, Baumann DP, Butler CE. Parastomal hernia repair. Plast Aesthet Res. 2023 Feb;9(10).

 
Editing

Zhang X, Yao J, Niu N, et al. SOX17: A Highly Sensitive and Specific Immunomarker for Ovarian and Endometrial Carcinomas. Mod Pathol. 2023 Feb;36(2):100001.

 
Editing

Meernik C, Jorgensen K, Wu C-F, et al. Disparities in the use of assisted reproductive technologies after breast cancer: a population-based study. Breast Cancer Res Treat. 2023 Feb;198(1):149-158.

 
Editing

Zeng Z, Maiti A, Herbrich S, et al. Triple combination targeting methyltransferase, BCL-2, and PD-1 facilitates antileukemia responses in acute myeloid leukemia. Cancer. 2023 Feb 15;129(4):531-540.

 
Editing

Contrera KJ, Gule-Monroe M, Hu MI, et al. Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series. Thyroid. 2023 Jan;33(1):129-132.

 
Editing

An C, Pipia I, Ruiz A-S, et al. The molecular link between obesity and genomic instability in cancer development. Cancer Lett. 2023 Feb 28;555:216035.

 

January 2023

Contribution Citation Altmetric Badge
Editing

Joo L, Bradley CC, Lin SH, Scheet PA, Nead KT. Causes of Clonal Hematopoiesis: a Review. Curr Oncol Rep. 2023 Jan 31.

 
Editing

Jenq R, Hayase E, Hayase T, et al. Bacteroides ovatus alleviates dysbiotic microbiota-induced intestinal graft-versus-host disease. Res Sq. 2023 Jan 31;rs.3.rs-2460097.

 
Editing

Lin Y-M, Paolucci I, O’Connor CS, et al. Ablative Margins of Colorectal Liver Metastases Using Deformable CT Image Registration and Autosegmentation. Radiology. 2023 Jan 31;221373.

 
Editing

Szvalb AD, Yepez Guevara E, Euscher E, Nahmod KA, Kontoyiannis DP. Acute Peritoneal Histoplasmosis Mimicking Ovarian Cancer and Review of the Literature on Histoplasma Peritonitis. Open Forum Infect Dis. 2023 Jan 10;10(1):ofac705.

 
Editing

Zhao J, Jiang X, Hanna E, et al. Orbital and periocular complications in patients with sinonasal tumours with orbital invasion. Br J Ophthalmol. 2023 Jan 27.

 
Editing

He J, Munir F, Ragoonanan D, et al. Combining CAR T Cell Therapy and Oncolytic Virotherapy for Pediatric Solid Tumors: A Promising Option. Immuno. 2023 Jan 20;3(1):37-56.

 
Editing

Zhou Z, Adrada BE, Candelaria RP, et al. Prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer using deep learning on multiparametric MRI. Sci Rep. 2023 Jan 20;13(1):1171.

 
Editing

Moawad AW, Morshid A, Khalaf AM, et al. Multimodality annotated hepatocellular carcinoma data set including pre- and post-TACE with imaging segmentation. Sci Data. 2023 Jan 18;10(1):33.

 
Editing

Dasgupta P, Balasubramanyian V, de Groot JF, Majd NK. Preclinical Models of Low-Grade Gliomas. Cancers (Basel). 2023 Jan 18;15(3):596.

 
Editing

Hong DS, Van Tine BA, Biswas S, et al. Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial. Nat Med. 2023 Jan;29(1):104-114.

 
Editing

Son J, Lin HY, Fu S, et al. Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer. J Immunother Precis Oncol. 2023 Jan 6;6(1):10-18.

 
Editing

Vauthey J-N. SSAT 2022 Presidential Address: 7 Things to Love About SSAT. J Gastrointest Surg. 2023 Jan 5;1-9.

 
Editing

Paolucci I, Lin Y-M, Jones AK, Brock KK, Odisio BC. Use of Contrast Media During CT-guided Thermal Ablation of Colorectal Liver Metastasis for Procedure Planning is Associated with Improved Immediate Outcomes. Cardiovasc Intervent Radiol. 2023 Jan 6.

 
Editing

Yoshida-Court K, Karpinets TV, Mitra A, et al. Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancer. PLoS One. 2023 Jan 6;18(1):e0279590.

 
Editing

Kim K, Ong F, Sasaki K. Current Understanding of DDX41 Mutations in Myeloid Neoplasms. Cancers (Basel). 2023 Jan 5;15(2):344.

 
Editing

Li X, Zhong Y, Zhang X, Sood AK, Liu J. Spatiotemporal view of malignant histogenesis and macroevolution via formation of polyploid giant cancer cells. Oncogene. 2023 Jan 3.

 
Editing

Hui D, Paiva BSR, Paiva CE. Personalizing the Setting of Palliative Care Delivery for Patients with Advanced Cancer: "Care Anywhere, Anytime". Curr Treat Options Oncol. 2023 Jan;24(1):1-11.